{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:34:33Z","timestamp":1792661673924,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jconrel.2022.11.004","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T06:51:27Z","timestamp":1668149487000},"page":"793-812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"special_numbering":"C","title":["Metabolic reprogramming mediated PD-L1 depression and hypoxia reversion to reactivate tumor therapy"],"prefix":"10.1016","volume":"352","author":[{"given":"Zaigang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaian","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianliang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.11.004_bb0005","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1158\/1078-0432.CCR-19-0673","article-title":"Photodynamic therapy for the treatment of vertebral metastases: a phase I clinical trial","volume":"25","author":"Fisher","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2020.101698","article-title":"Clinical trial of photodynamic therapy for peripheral-type lung cancers using a new laser device in a pilot study","volume":"30","author":"Usuda","year":"2020","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121332","article-title":"Engineering bioluminescent bacteria to boost photodynamic therapy and systemic anti-tumor immunity for synergistic cancer treatment","volume":"281","author":"Yang","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.11.004_bb0020","first-page":"97","article-title":"Photosynthetic microorganisms coupled photodynamic therapy for enhanced antitumor immune effect","volume":"12","author":"Wang","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0025","article-title":"Construction of enzyme nanoreactors to enable tumor microenvironment modulation and enhanced cancer treatment","volume":"10","author":"Liu","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120621","article-title":"Light-controlled oxygen production and collection for sustainable photodynamic therapy in tumor hypoxia","volume":"269","author":"Wang","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.11.004_bb0035","doi-asserted-by":"crossref","first-page":"13473","DOI":"10.1039\/D1NR02880D","article-title":"Effective tumor vessel barrier disruption mediated by perfluoro-N-(4-methylcyclohexyl) piperidine nanoparticles to enhance the efficacy of photodynamic therapy","volume":"13","author":"Xiong","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2022.11.004_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201801694","article-title":"Perfluorocarbon nanoparticles mediated platelet blocking disrupt vascular barriers to improve the efficacy of oxygen-sensitive antitumor drugs","volume":"14","author":"Zhou","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2022.11.004_bb0045","doi-asserted-by":"crossref","first-page":"8026","DOI":"10.1021\/acsami.0c21743","article-title":"Metformin liposome-mediated PD-L1 downregulation for amplifying the photodynamic immunotherapy efficacy","volume":"13","author":"Xiong","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.11.004_bb0050","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1021\/acs.molpharmaceut.8b00997","article-title":"Enhancing anti-PD-1\/PD-L1 immune checkpoint inhibitory cancer therapy by CD276-targeted photodynamic ablation of tumor cells and tumor vasculature","volume":"16","author":"Bao","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202102668","article-title":"Engineering chameleon prodrug nanovesicles to increase antigen presentation and inhibit PD-L1 expression for circumventing immune resistance of cancer","volume":"33","author":"Zhou","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0060","article-title":"Endogenous stimuli-activatable nanomedicine for immune theranostics for cancer","volume":"31","author":"Wang","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0065","doi-asserted-by":"crossref","first-page":"11972","DOI":"10.1073\/pnas.1901987116","article-title":"Perfluorocarbon nanoparticle-mediated platelet inhibition promotes intratumoral infiltration of T cells and boosts immunotherapy","volume":"116","author":"Zhou","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0070","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.7150\/thno.27598","article-title":"Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles","volume":"8","author":"Zhou","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2022.11.004_bb0075","doi-asserted-by":"crossref","first-page":"38906","DOI":"10.1021\/acsami.0c08389","article-title":"Multifunctional smart yolk-shell nanostructure with mesoporous MnO2 Shell for enhanced cancer therapy","volume":"12","author":"Zhuang","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.11.004_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201905823","article-title":"Manganese oxide nanomaterials: synthesis, properties, and theranostic applications","volume":"32","author":"Ding","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0085","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.biomaterials.2018.08.011","article-title":"Photosensitizer-crosslinked in-situ polymerization on catalase for tumor hypoxia modulation & enhanced photodynamic therapy","volume":"181","author":"Wang","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.11.004_bb0090","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jconrel.2020.05.029","article-title":"Current developments in nanotechnology for improved cancer treatment, focusing on tumor hypoxia","volume":"324","author":"Phung","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.11.004_bb0095","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12951-021-01144-4","article-title":"Oxygen nanocarrier broke the hypoxia trap of solid tumors and rescued transfection efficiency for gene therapy","volume":"19","author":"Qin","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0100","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/j.1742-4658.2007.05686.x","article-title":"Energy metabolism in tumor cells","volume":"274","author":"Moreno-Sanchez","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0105","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12951-021-01034-9","article-title":"Atovaquone-HSA nano-drugs enhance the efficacy of PD-1 blockade immunotherapy by alleviating hypoxic tumor microenvironment","volume":"19","author":"Wang","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0110","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1021\/acs.nanolett.0c00047","article-title":"Self-delivery nanomedicine for O2-economized photodynamic tumor therapy","volume":"20","author":"Zhao","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0115","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1021\/jacs.0c00734","article-title":"Unimolecular photodynamic O2-economizer to overcome hypoxia resistance in phototherapeutics","volume":"142","author":"Li","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0120","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ijrobp.2004.01.039","article-title":"Synergistic effects of hyperoxic gas breathing and reduced oxygen consumption on tumor oxygenation: a theoretical model","volume":"59","author":"Secomb","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0125","first-page":"133","article-title":"A cleavable self-delivery nanoparticle for tumor photo-immunotherapy","volume":"16","author":"Hu","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0130","doi-asserted-by":"crossref","first-page":"7456","DOI":"10.1039\/D1BM01303C","article-title":"A metformin-based nanoreactor alleviates hypoxia and reduces ATP for cancer synergistic therapy","volume":"9","author":"Meng","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118869","article-title":"Chitosan oligosaccharide regulates AMPK and STAT1 pathways synergistically to mediate PD-L1 expression for cancer chemoimmunotherapy","volume":"277","author":"Chen","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12951-021-01124-8","article-title":"Selectively down-regulated PD-L1 by albumin-phenformin nanoparticles mediated mitochondrial dysfunction to stimulate tumor-specific immunological response for enhanced mild-temperature photothermal efficacy","volume":"19","author":"Zhou","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0145","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.molcel.2018.07.030","article-title":"Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1","volume":"71","author":"Cha","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2022.11.004_bb0150","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/s41419-020-03140-2","article-title":"PD-L1 degradation pathway and immunotherapy for cancer","volume":"11","author":"Gou","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0155","doi-asserted-by":"crossref","first-page":"32763","DOI":"10.1021\/acsami.1c07323","article-title":"Immune\/hypoxic tumor microenvironment regulation-enhanced photodynamic treatment realized by pH-responsive phase transition-targeting nanobubbles","volume":"13","author":"Zhao","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.11.004_bb0160","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.biopha.2018.07.085","article-title":"A preclinical overview of metformin for the treatment of type 2 diabetes","volume":"106","author":"Zhou","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14010112","article-title":"Frontiers in anti-cancer drug discovery: challenges and perspectives of metformin as anti-angiogenic add-on therapy in glioblastoma","volume":"14","author":"Guarnaccia","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"41","key":"10.1016\/j.jconrel.2022.11.004_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202206121","article-title":"Tumor selective metabolic reprogramming as a prospective PD-L1 depression strategy to reactivate immunotherapy","volume":"34","author":"Liu","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119878","article-title":"Chitosan biguanide induced mitochondrial inhibition to amplify the efficacy of oxygen-sensitive tumor therapies","volume":"295","author":"Zhou","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0180","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1017\/S0954422415000062","article-title":"Energy restriction and potential energy restriction mimetics","volume":"28","author":"Nikolai","year":"2015","journal-title":"Nutr. Res. Rev."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0185","first-page":"399","article-title":"Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs","volume":"16","author":"Daniels","year":"2016","journal-title":"Pharm. J."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0190","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1158\/0008-5472.CAN-15-2534","article-title":"Mitochondria-targeted analogues of metformin exhibit enhanced antiproliferative and radiosensitizing effects in pancreatic cancer cells","volume":"76","author":"Cheng","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0195","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2337\/diab.24.9.791","article-title":"Phenformin-induced lactic acidosis in diabetic patients","volume":"24","author":"Assan","year":"1975","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2022.11.004_bb0200","doi-asserted-by":"crossref","first-page":"8308","DOI":"10.1021\/acsnano.8b03590","article-title":"Tumor oxygenation and hypoxia inducible factor-1 functional inhibition via a reactive oxygen species responsive nanoplatform for enhancing radiation therapy and abscopal effects","volume":"12","author":"Meng","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.11.004_bb0205","doi-asserted-by":"crossref","first-page":"7152","DOI":"10.1039\/C9TB02002K","article-title":"The controllable growth of ultrathin MnO2 on polydopamine nanospheres as a single nanoplatform for the MRI-guided synergistic therapy of tumors","volume":"7","author":"Sun","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2022.11.004_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121307","article-title":"A multifunctional nanoamplifier with self-enhanced acidity and hypoxia relief for combined photothermal\/photodynamic\/starvation therapy","volume":"611","author":"Li","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0215","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1039\/D1FO00032B","article-title":"MnO2 nanosheets anchored with polypyrrole nanoparticles as a multifunctional platform for combined photothermal\/photodynamic therapy of tumors","volume":"12","author":"Li","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0220","doi-asserted-by":"crossref","first-page":"2002746","DOI":"10.1002\/advs.202002746","article-title":"Regulating glucose metabolism with prodrug nanoparticles for promoting photoimmunotherapy of pancreatic cancer","volume":"8","author":"Sun","year":"2021","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.jconrel.2022.11.004_bb0225","article-title":"Catalase nanocrystals loaded with methylene blue as oxygen self-supplied, imaging-guided platform for photodynamic therapy of hypoxic tumors","volume":"17","author":"Zhou","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2022.11.004_bb0230","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911571","article-title":"Blocking interaction between SHP2 and PD-1 denotes a novel opportunity for developing PD-1 inhibitors","volume":"12","author":"Fan","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jconrel.2022.11.004_bb0235","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jconrel.2020.10.031","article-title":"Perdurable PD-1 blockage awakes anti-tumor immunity suppressed by precise chemotherapy","volume":"329","author":"Jiang","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.11.004_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27030731","article-title":"Advances in management of bladder cancer-the role of photodynamic therapy","volume":"27","author":"Kubrak","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2022.11.004_bb0245","article-title":"D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1","volume":"119","author":"Zhang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592200743X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592200743X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:40:33Z","timestamp":1759164033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592200743X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":49,"alternative-id":["S016836592200743X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.11.004","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic reprogramming mediated PD-L1 depression and hypoxia reversion to reactivate tumor therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}